Fernwood Investment Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Fernwood Investment Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$237K	Hold	15,000	–	–	0.08%	148
2024 Q3	$238K	Hold	15,000	–	–	0.08%	165
2024 Q2	$229K	Hold	15,000	–	–	0.07%	179
2024 Q1	$220K	Hold	15,000	–	–	0.06%	188
2023 Q4	$209K	Hold	15,000	–	–	0.07%	183
2023 Q3	$201K	Buy	+15,000	New	+$203K	0.07%	182
2021 Q3	–	Sell	-15,000	Closed	-$221K	–	203
2021 Q2	$221K	Buy	+15,000	New	+$210K	0.07%	187
2021 Q1	–	Sell	-15,000	Closed	-$214K	–	197
2020 Q4	$214K	Hold	15,000	–	–	0.08%	172
2020 Q3	$209K	Buy	+15,000	New	+$179K	0.1%	156

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Fernwood Investment Management's RDY Position: Q4 2024 in Review

Fernwood Investment Management held its Dr. Reddy's Laboratories (RDY) position steady in Q4 2024 at 15,000 shares worth $237K. The position accounts for 0.08% of the portfolio, ranked #148.

Fernwood Investment Management first reported a position in RDY in Q3 2020 and has held it in 9 quarters since. The position peaked at $238K in Q3 2024. 248 funds tracked by Wall St. Rank hold RDY as of Q4 2024.

Fernwood Investment Management held 15,000 shares of Dr. Reddy's Laboratories worth $237K as of Q4 2024.
Fernwood Investment Management left its Dr. Reddy's Laboratories share count unchanged in Q4 2024.
Dr. Reddy's Laboratories made up 0.08% of Fernwood Investment Management's portfolio in Q4 2024, its #148 holding.
Fernwood Investment Management first reported a position in Dr. Reddy's Laboratories in Q3 2020 and has held it in 9 quarters since.
Fernwood Investment Management's Dr. Reddy's Laboratories position peaked at $238K in Q3 2024.
248 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2024.

Based on Fernwood Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.